Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.81 - $3.43 $114,021 - $482,830
-140,767 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$3.37 - $6.87 $119,564 - $243,740
35,479 Added 33.7%
140,767 $552,000
Q3 2021

Nov 12, 2021

BUY
$5.78 - $7.86 $608,564 - $827,563
105,288 New
105,288 $706,000
Q4 2020

Feb 12, 2021

SELL
$8.48 - $12.23 $196,752 - $283,760
-23,202 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$9.99 - $14.41 $231,787 - $334,340
23,202 New
23,202 $253,000
Q1 2020

May 11, 2020

SELL
$11.31 - $18.26 $198,083 - $319,805
-17,514 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$6.44 - $14.21 $112,790 - $248,873
17,514 New
17,514 $245,000

Others Institutions Holding MTEM

About Molecular Templates, Inc.


  • Ticker MTEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,351,600
  • Market Cap $7.33M
  • Description
  • Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...
More about MTEM
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.